At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Restricted Fluid Administrationother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effects Of Intraoperative Different Fluid Therapy Protocols On Postoperative Renal Functions
In Brief
A clinical study evaluating Restricted Fluid Administration for Intraoperative Fluid Management. Completed, enrolled 60 participants across 1 site.
Detailed Summary
We aimed to evaluate the relationship between different intraoperative fluid therapy protocols and postoperative renal damage and mortality.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntraoperative Fluid Management
CountriesTurkey (Türkiye)
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJan 2022
Primary CompletionDec 2022
Study CompletionMay 2023
First PostedJan 2024
TodayJul 2026
First PostedJan 3, 2024
Enrollment StartJan 20, 2022
Primary CompletionDec 1, 2022
Study CompletionMay 15, 2023
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 2.5 years ago
Interventions
Restricted Fluid Administrationother
Restrictive fluid administration generally consists of partial or no replacement for the intravascular expansion from anesthesia, in which case vasopressors are usually administered, no replacement for the third space loss, and only partial replacement for deficits from preoperative fasting.